• tyc7111cc太阳成集团

    洞察市场格局
    解锁药品研发情报

    免费客服电话

    18983288589
    医药数据查询

    【ChiCTR-IIR-17011735】Single shot versus continuous saphenous nerve block for postoperative pain management after total knee replacement: a randomised, double-blind trial

    基本信息
    登记号

    ChiCTR-IIR-17011735

    试验状态

    尚未开始

    药物名称

    /

    药物类型

    /

    规范名称

    /

    首次公示信息日的期

    2017-06-22

    临床申请受理号

    /

    靶点

    /

    适应症

    Primary osteoarthritis of knee undergoing total knee replacement

    试验通俗题目

    Single shot versus continuous saphenous nerve block for postoperative pain management after total knee replacement: a randomised, double-blind trial

    试验专业题目

    Single shot versus continuous saphenous nerve block for postoperative pain management after total knee replacement: a randomised, double-blind trial

    申办单位信息
    申请人联系人
    申请人名称
    联系人邮箱
    联系人邮编

    852

    联系人通讯地址
    临床试验信息
    试验目的

    To investigate and compare the effect of single shot versus continuous saphenous nerve blockade on pain control in the early postoperative period for patients undergoing unilateral primary total knee replacement.

    试验分类
    试验类型

    随机平行对照

    试验分期

    Ⅳ期

    随机化

    Randomization will be performed by computer program and the results will be sealed in concealed envelops.

    盲法

    /

    试验项目经费来源

    Departmental funding

    试验范围

    /

    目标入组人数

    30

    实际入组人数

    /

    第一例入组时间

    2017-10-01

    试验终止时间

    2018-06-30

    是否属于一致性

    /

    入选标准

    1. Primary, unilateral total knee replacement under central neuroaxial block; 2. Aged 18 to 80 years; 3. American Society of Anesthesiologists (ASA) physical status I – III.；

    排除标准

    1. Patients with secondary osteoarthritis of the knee; 2. Patients undergoing operation under general anaesthesia; 3. Pregnancy; 4. Body weight < 45 kg or body mass index > 40 kg/m2; 5. Allergy to opioid or local anaesthetics; 6. Patients with contraindications to COX-2 inhibitors use; 7. Chronic opioid use (> 1 month of 60mg morphine oral equivalents daily); 8. Subject refusal.；

    研究者信息
    研究负责人姓名
    试验机构

    Department of Anaesthesia and Intensive Care, Pok Oi Hospital

    研究负责人电话
    研究负责人邮箱
    研究负责人邮编

    852

    联系人通讯地址

    最新临床资讯

    tyc7111cc太阳成集团企业版
    50亿+条医药数据随时查
    7天免费试用
    体验产品